{"id":"https://openalex.org/W2005104005","doi":"https://doi.org/10.1097/00002030-200001070-00019","title":"In-vitro tipranavir susceptibility of HIV-1 isolates with reduced susceptibility to other protease inhibitors","display_name":"In-vitro tipranavir susceptibility of HIV-1 isolates with reduced susceptibility to other protease inhibitors","alternate_titles":[],"publication_year":2000,"publication_date":"2000-01-01","ids":{"openalex":"https://openalex.org/W2005104005","doi":"https://doi.org/10.1097/00002030-200001070-00019","mag":"2005104005","pmid":"https://pubmed.ncbi.nlm.nih.gov/10714580"},"language":"en","primary_location":{"id":"doi:10.1097/00002030-200001070-00019","doi":"https://doi.org/10.1097/00002030-200001070-00019","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002030-200001070-00019","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005104005"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111700075","display_name":"Nicole K.T. Back","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Nicole K.T. Back","raw_affiliation_strings":["Department of Virology, Eijkman-Winkler Institute, University Hospital Utrecht, Utrecht, the Netherlands","Received: 14 September 1999","accepted: 30 September 1999"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Virology, Eijkman-Winkler Institute, University Hospital Utrecht, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I3018483916"]},{"raw_affiliation_string":"Received: 14 September 1999","institution_ids":[]},{"raw_affiliation_string":"accepted: 30 September 1999","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112256117","display_name":"Albert van Wijk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Albert van Wijk","raw_affiliation_strings":["Department of Virology, Eijkman-Winkler Institute, University Hospital Utrecht, Utrecht, the Netherlands","Received: 14 September 1999","accepted: 30 September 1999"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Virology, Eijkman-Winkler Institute, University Hospital Utrecht, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I3018483916"]},{"raw_affiliation_string":"Received: 14 September 1999","institution_ids":[]},{"raw_affiliation_string":"accepted: 30 September 1999","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5098587960","display_name":"DaniMlle Remmerswaal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"DaniMlle Remmerswaal","raw_affiliation_strings":["Department of Virology, Eijkman-Winkler Institute, University Hospital Utrecht, Utrecht, the Netherlands","Received: 14 September 1999","accepted: 30 September 1999"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Virology, Eijkman-Winkler Institute, University Hospital Utrecht, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I3018483916"]},{"raw_affiliation_string":"Received: 14 September 1999","institution_ids":[]},{"raw_affiliation_string":"accepted: 30 September 1999","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5098141360","display_name":"Marion van Monfort","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Marion van Monfort","raw_affiliation_strings":["Department of Virology, Eijkman-Winkler Institute, University Hospital Utrecht, Utrecht, the Netherlands","Received: 14 September 1999","accepted: 30 September 1999"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Virology, Eijkman-Winkler Institute, University Hospital Utrecht, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I3018483916"]},{"raw_affiliation_string":"Received: 14 September 1999","institution_ids":[]},{"raw_affiliation_string":"accepted: 30 September 1999","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002497082","display_name":"Monique Nijhuis","orcid":"https://orcid.org/0000-0001-6610-8282","observed_orcids":["https://orcid.org/0000-0001-6610-8282"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Monique Nijhuis","raw_affiliation_strings":["Department of Virology, Eijkman-Winkler Institute, University Hospital Utrecht, Utrecht, the Netherlands","Received: 14 September 1999","accepted: 30 September 1999"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Virology, Eijkman-Winkler Institute, University Hospital Utrecht, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I3018483916"]},{"raw_affiliation_string":"Received: 14 September 1999","institution_ids":[]},{"raw_affiliation_string":"accepted: 30 September 1999","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017678982","display_name":"Rob Schuurman","orcid":"https://orcid.org/0000-0002-0060-9831","observed_orcids":["https://orcid.org/0000-0002-0060-9831"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Rob Schuurman","raw_affiliation_strings":["Department of Virology, Eijkman-Winkler Institute, University Hospital Utrecht, Utrecht, the Netherlands","Received: 14 September 1999","accepted: 30 September 1999"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Virology, Eijkman-Winkler Institute, University Hospital Utrecht, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I3018483916"]},{"raw_affiliation_string":"Received: 14 September 1999","institution_ids":[]},{"raw_affiliation_string":"accepted: 30 September 1999","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103011545","display_name":"Charles A. Boucher","orcid":"https://orcid.org/0000-0003-0892-5473","observed_orcids":["https://orcid.org/0000-0003-0892-5473"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Charles A.B. Boucher","raw_affiliation_strings":["Department of Virology, Eijkman-Winkler Institute, University Hospital Utrecht, Utrecht, the Netherlands","Received: 14 September 1999","accepted: 30 September 1999"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Virology, Eijkman-Winkler Institute, University Hospital Utrecht, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I3018483916"]},{"raw_affiliation_string":"Received: 14 September 1999","institution_ids":[]},{"raw_affiliation_string":"accepted: 30 September 1999","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I3018483916"],"apc_list":null,"apc_paid":null,"fwci":4.9301,"has_fulltext":false,"cited_by_count":105,"citation_normalized_percentile":{"value":0.95158375,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"14","issue":"1","first_page":"101","last_page":"102"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tipranavir","display_name":"tipranavir","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hiv-1-protease-inhibitors","display_name":"HIV-1 protease inhibitors","score":0.9639999866485596},{"id":"https://openalex.org/keywords/protease-inhibitor-resistance","display_name":"protease inhibitor resistance","score":0.8130000233650208},{"id":"https://openalex.org/keywords/reduced-susceptibility","display_name":"reduced susceptibility","score":0.4269999861717224},{"id":"https://openalex.org/keywords/antiretroviral-drug-susceptibility","display_name":"antiretroviral drug susceptibility","score":0.7080000042915344}],"concepts":[{"id":"https://openalex.org/C2776937687","wikidata":"https://www.wikidata.org/wiki/Q422654","display_name":"Saquinavir","level":5,"score":0.9434438347816467},{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.797646701335907},{"id":"https://openalex.org/C2777210460","wikidata":"https://www.wikidata.org/wiki/Q425490","display_name":"Indinavir","level":5,"score":0.773329496383667},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.6936020851135254},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6427040696144104},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.6295025944709778},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5227254033088684},{"id":"https://openalex.org/C2777363262","wikidata":"https://www.wikidata.org/wiki/Q422198","display_name":"Amprenavir","level":5,"score":0.43630021810531616},{"id":"https://openalex.org/C2777583353","wikidata":"https://www.wikidata.org/wiki/Q410261","display_name":"HIV-1 protease","level":4,"score":0.39862772822380066},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.15232419967651367},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12551051378250122},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.11475709080696106},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.10980468988418579},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.08020806312561035},{"id":"https://openalex.org/C2776452011","wikidata":"https://www.wikidata.org/wiki/Q311463","display_name":"Sida","level":4,"score":0.07761877775192261},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004352","descriptor_name":"Drug Resistance, Microbial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008969","descriptor_name":"Molecular Sequence Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011753","descriptor_name":"Pyrones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020133","descriptor_name":"Reverse Transcriptase Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00002030-200001070-00019","doi":"https://doi.org/10.1097/00002030-200001070-00019","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002030-200001070-00019","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},{"id":"pmid:10714580","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10714580","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS (London, England)","raw_type":"Letter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1651794786","https://openalex.org/W1906845464","https://openalex.org/W2102486137","https://openalex.org/W2104681175","https://openalex.org/W2106197195","https://openalex.org/W2106571163","https://openalex.org/W2166229810"],"related_works":["https://openalex.org/W2007788465","https://openalex.org/W2000176602","https://openalex.org/W2010933020","https://openalex.org/W3191422891","https://openalex.org/W1981719094","https://openalex.org/W1985285378","https://openalex.org/W1566064579","https://openalex.org/W2127537255","https://openalex.org/W2140708560","https://openalex.org/W1984639382"],"abstract_inverted_index":{"Tipranavir":[0,522],"(PNU-140690)":[1],"is":[2,42,61,484,523],"a":[3,32,172,190,209,292,317,334,425,487,512,524,532,569],"non-peptidic":[4],"HIV-1":[5,35,47,76,287,345],"protease":[6,55,85,106,113,165,201,224,351,378,388,393,453,517,525,541],"inhibitor":[7,56,389,518,526],"of":[8,34,74,105,112,117,171,199,222,226,294,296,303,316,372,383,404,472,490,527,535],"the":[9,53,69,102,140,161,223,227,233,247,277,286,301,313,342,350,361,381,405,445,538,562],"5,6-dihydro-4-hydroxy-2-pyrone":[10],"sulfonamide":[11],"class,":[12],"which":[13],"has":[14],"resulted":[15],"from":[16,109,139,168],"structure-based":[17],"design":[18],"efforts":[19],"at":[20,291,332],"Pharmacia":[21],"and":[22,38,163,187,208,241,261,298,356,369,386,401,461,478,498,504,530,553],"Upjohn":[23],"[1]":[24],"In":[25,154,456],"addition":[26],"to":[27,52,81,147,269,275,341,410,416,420,430,442,451,474,547],"having":[28],"good":[29],"potency":[30],"against":[31,45,486,516],"variety":[33],"laboratory":[36,46],"strains":[37],"clinical":[39,64,75,110,373,467,492,520],"isolates,":[40],"tipranavir":[41,73,357,443,483,510],"highly":[43],"active":[44,485],"isolates":[48,77,364,374,406,447,468],"that":[49,482,509],"are":[50,329,545,559],"resistant":[51,491],"peptidomimetic":[54],"ritonavir":[57,176,421],"[2,3]":[58],"The":[59,197,219,239,258,347],"drug":[60,278,305,318,327,338],"currently":[62],"under":[63],"evaluation.":[65],"Here":[66],"we":[67,437],"investigate":[68,548],"viral":[70,363],"susceptibility":[71,80,279,319,328,339,348,409,419,429,450],"for":[72,97,265,349,360,444,564],"with":[78,126,160,175,285,376,448,469,531,568],"reduced":[79,408,418,449],"other":[82,452],"substrate":[83,539],"analogue":[84,540],"inhibitors,":[86],"in":[87,181,189,273,300,322,326,337,428,433,561],"particular":[88],"ritonavir,":[89,354,476],"indinavir":[90,503],"or":[91,152],"saquinavir.":[92],"Recombinant":[93,412],"viruses":[94,157,272,413],"were":[95,132,158,203,230,244,267],"used":[96,264,268],"this":[98,434],"study,":[99],"created":[100,159],"using":[101,205,232,246],"amplified":[103,162,188,200,220,260],"pool":[104,198],"genes":[107,166,202],"obtained":[108,138,167],"samples":[111,137,170],"inhibitor-treated":[114],"individuals.":[115],"Samples":[116],"patients":[118,142],"extensively":[119],"treated":[120,174,375],"(for":[121],"more":[122],"than":[123,537],"1":[124],"year)":[125],"saquinavir":[127,148],"(hard":[128],"capsule":[129],"formulation,":[130,150],"Invirase)":[131],"analysed":[133],"as":[134,136],"well":[135],"same":[141,259],"8":[143],"weeks":[144],"after":[145],"switching":[146],"(oral":[149],"Fortovase)":[151],"indinavir.":[153],"addition,":[155,457],"recombinant":[156,271,288],"cloned":[164,231,262],"longitudinal":[169],"patient":[173,229],"(M.":[177],"Nijhuis,":[178],"et":[179],"al.,":[180],"press).":[182],"RNA":[183],"was":[184,283,358],"first":[185],"extracted":[186],"(nested)":[191],"reverse":[192],"transcriptase\u2013polymerase":[193],"chain":[194],"reaction":[195],"[4\u20136]":[196],"sequenced":[204,245],"dye":[206,249],"primers":[207],"Applied":[210],"Biosystems":[211,256],"International":[212],"(Foster":[213],"city,":[214],"CA,":[215],"USA)":[216],"automated":[217],"sequencer.":[218],"products":[221],"gene":[225],"ritonavir-treated":[228],"TA":[234],"cloning":[235],"system":[236],"(Invitrogen":[237],"Leek,":[238],"Netherlands),":[240],"these":[242],"clones":[243],"taq":[248],"deoxy":[250],"terminator":[251],"cycle":[252],"sequencing":[253,266],"kit":[254],"(Applied":[255],"International).":[257],"fragments":[263],"generate":[270],"order":[274],"determine":[276],"[7,8]":[280],"This":[281],"assay":[282,320],"conducted":[284],"stock":[289],"virus":[290],"multiplicity":[293],"infection":[295],"0.002":[297],"0.006":[299],"presence":[302,382],"increasing":[304],"concentrations":[306,310],"[9]":[307],"All":[308],"IC50":[309],"indicated":[311],"reflect":[312],"geometric":[314],"mean":[315],"performed":[321],"duplicate.":[323],"Significant":[324],"changes":[325],"defined":[330],"by":[331,459,496],"least":[333],"threefold":[335],"change":[336,427],"relative":[340],"reference":[343],"strain":[344],"HXB2.":[346],"inhibitors":[352,454],"indinavir,":[353,475],"saquinavir,":[355,479],"determined":[359],"selected":[362],"(Table":[365],"1).Table":[366],"1:":[367],"Phenotypic":[368],"genotypic":[370],"analysis":[371],"different":[377,533,570],"inhibitors.":[379,542],"Despite":[380],"known":[384],"primary":[385],"secondary":[387],"resistance":[390,551,571],"mutations":[391],"(e.g.":[392],"positions":[394],"10,":[395],"20,":[396],"36,":[397],"63,":[398],"71,":[399],"82":[400],"90),":[402],"none":[403],"showed":[407,481],"tipranavir.":[411,431],"demonstrating":[414],"up":[415],"24-fold":[417],"did":[422,438],"not":[423,439],"show":[424],"significant":[426],"Therefore":[432],"small":[435],"study":[436],"observe":[440],"cross-resistance":[441,473],"11":[446],"[10]":[455],"studies":[458,495,544],"Larder":[460],"coworkers":[462,499],"[11]":[463],"who":[464],"tested":[465],"125":[466],"varying":[470],"degrees":[471],"nelfinavir":[477],"also":[480],"large":[488],"selection":[489],"samples.":[493],"Other":[494],"Rusconi":[497],"[12]":[500],"evaluated":[501],"both":[502],"ritonavir-resistant":[505],"isolates.":[506,521],"They":[507],"concluded":[508],"retained":[511],"sustained":[513],"antiviral":[514,554,566],"activity":[515],"multidrug-resistant":[519],"another":[528],"class":[529],"mechanism":[534],"inhibition":[536],"Further":[543],"needed":[546],"its":[549],"possible":[550],"pattern":[552],"activity.":[555],"However,":[556],"our":[557],"results":[558],"promising":[560],"search":[563],"new":[565],"compounds":[567],"pattern.":[572],"Nicole":[573],"K.T.":[574],"Back":[575],"Albert":[576],"van":[577,582],"Wijk":[578],"DaniMlle":[579],"Remmerswaal":[580],"Marion":[581],"Monfort":[583],"Monique":[584],"Nijhuis":[585],"Rob":[586],"Schuurman":[587],"Charles":[588],"A.B.":[589],"Boucher":[590]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005104005","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
